Login| Sign Up| Help| Contact|

Patent Searching and Data


Title:
DEUTERATED OLIGONUCLEOTIDE AND PRODRUG
Document Type and Number:
WIPO Patent Application WO/2019/219070
Kind Code:
A1
Abstract:
The present invention belongs to the field of medicinal chemistry and relates to a deuterated oligonucleotide and a prodrug. In particular, the present invention relates to a compound represented by formula I or a pharmaceutically acceptable salt thereof, a preparation method, a pharmaceutical composition, and a medical use. The medical use comprises a use in treating hepatitis B virus infection, especially a liver disease caused by hepatitis B virus infection.

Inventors:
ZHANG YINSHENG (CN)
LIU BAOMIN (CN)
HUANG YU (CN)
ZHU YAN (CN)
ZHANG YANG (CN)
TONG SHUNYU (CN)
WANG XIAOJIN (CN)
XU HONGJIANG (CN)
Application Number:
PCT/CN2019/087349
Publication Date:
November 21, 2019
Filing Date:
May 17, 2019
Export Citation:
Click for automatic bibliography generation   Help
Assignee:
CHIA TAI TIANQING PHARMACEUTICAL GROUP CO LTD (CN)
International Classes:
A61K31/7072; C07H19/20; A61P31/14
Domestic Patent References:
WO2007070598A22007-06-21
WO2002092006A22002-11-21
Foreign References:
CN106699828A2017-05-24
CN105669751A2016-06-15
Other References:
LIU JIE: "Deuterated Drugs Progress", PHARMACEUTICAL AND CHEMICAL, vol. 42, no. 4, 30 April 2016 (2016-04-30), pages 199 - 238
Attorney, Agent or Firm:
BEIJING SUNHOPE INTELLECTUAL PROPERTY LTD. (CN)
Download PDF: